journal article·2024-12-11Open access

IgG-Binding Peptidomimetic Mixed-Charge Polymer-Modified Resins for Chromatographic Purification of Antibodies

Koichi Deura, Akihiro Sakama, Yasuhiro Moriwaki, Daniel Citterio, Yuki Hiruta

ACS Applied Materials & Interfaces· Volume 16· Issue 49

Abstract

The process of antibody purification using Fc affinity ligands such as protein A, G, and L faces several challenges including high cost, low stability, and loss of antibody activity due to harsh elution conditions. Here, we describe a chromatographic purification of antibodies utilizing a pH-responsive mixed-charge polymer that mimics the IgG-binding peptide (Z34C) derived from the B domain of protein A. The protein A mimetic resins were prepared by modifying the surface of a TOYOPEARL, methacrylate resin with a polymer that mimics the amino acid sequence of Z34C and the functions of histidine and acidic and neutral amino acids using histamine methacrylamide (HisMA), methacrylic acid, and neutral monomers. The therapeutic monoclonal antibody (mAb), rituximab, was retained on the column at pH 7 and eluted under mildly acidic conditions at pH 5 using a protein A mimetic resin (HisMA20-EEMA) optimized for antibody interaction. The injected antibodies were selectively captured on the column by hydrophobic and electrostatic interactions with the protein A mimetic polymer under neutral conditions and eluted by electrostatic repulsion under acidic conditions. The HisMA20-EEMA column successfully purified mAbs from mixtures with BSA, mouse ascites fluid, and hybridoma cell culture supernatant. In addition, the HisMA20-EEMA column consistently achieved 90% antibody recovery in 100 consecutive purifications from cell culture supernatant. The antibody purification method presented in this study is low cost, highly durable, easy to synthesize, and allows for mild elution conditions. The results demonstrate that the approach of mimicking IgG-binding peptides with mixed-charge polymers is useful for the development of column packing materials for antibody purification.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Protein purification and stability · Glycosylation and Glycoproteins Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan

Division of Basic Biological Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan

Funding

Exploratory Research for Advanced Technology

References (49)

Show source-provided references
1. 10.1016/j.jchromb.2006.10.03310.1016/j.jchromb.2006.10.033 ↗
2. 10.1021/bp030070k10.1021/bp030070k ↗
3. 10.1021/acs.bioconjchem.7b0033510.1021/acs.bioconjchem.7b00335 ↗
4. 10.1016/j.jchromb.2006.09.03010.1016/j.jchromb.2006.09.030 ↗
5. 10.1016/j.ymeth.2016.12.01010.1016/j.ymeth.2016.12.010 ↗
6. 10.1016/j.jchromb.2006.09.02610.1016/j.jchromb.2006.09.026 ↗
7. 10.1016/j.chroma.2015.08.06810.1016/j.chroma.2015.08.068 ↗
8. 10.1021/bp070117s10.1021/bp070117s ↗
9. 10.1016/j.chroma.2008.12.00410.1016/j.chroma.2008.12.004 ↗
10. 10.1002/jmr.226510.1002/jmr.2265 ↗
11. 10.1016/j.aca.2018.02.01210.1016/j.aca.2018.02.012 ↗
12. 10.1021/acs.nanolett.0c0129710.1021/acs.nanolett.0c01297 ↗
13. 10.1016/j.chroma.2021.46194810.1016/j.chroma.2021.461948 ↗
14. 10.1021/acs.analchem.4c0005110.1021/acs.analchem.4c00051 ↗
15. 10.1016/S0021-9673(98)00436-110.1016/S0021-9673(98)00436-1 ↗
16. 10.1021/ac300952r10.1021/ac300952r ↗
17. 10.1021/acsami.0c1217110.1021/acsami.0c12171 ↗
18. 10.1016/j.cej.2024.14921610.1016/j.cej.2024.149216 ↗
19. 10.1016/j.pep.2009.11.00410.1016/j.pep.2009.11.004 ↗
20. 10.1016/j.jchromb.2015.09.01010.1016/j.jchromb.2015.09.010 ↗
21. 10.1016/j.chroma.2020.46160710.1016/j.chroma.2020.461607 ↗
22. 10.1016/j.cej.2020.12588710.1016/j.cej.2020.125887 ↗
23. 10.1016/j.jchromb.2021.12265210.1016/j.jchromb.2021.122652 ↗
24. 10.1016/j.chroma.2022.46369610.1016/j.chroma.2022.463696 ↗
25. 10.1007/s00604-024-06224-410.1007/s00604-024-06224-4 ↗
26. 10.1021/ja303612d10.1021/ja303612d ↗
27. 10.1038/s41428-022-00687-z10.1038/s41428-022-00687-z ↗
28. 10.1016/j.chroma.2018.07.02710.1016/j.chroma.2018.07.027 ↗
29. 10.1038/s41598-020-68707-710.1038/s41598-020-68707-7 ↗
30. 10.1016/j.colsurfb.2021.11189010.1016/j.colsurfb.2021.111890 ↗
31. 10.2147/IDR.S4922910.2147/IDR.S49229 ↗
32. 10.1021/mz500152710.1021/mz5001527 ↗
33. 10.1038/s41570-020-0215-y10.1038/s41570-020-0215-y ↗
34. 10.1021/acsnano.1c0264410.1021/acsnano.1c02644 ↗
35. 10.1021/jacs.1c1173710.1021/jacs.1c11737 ↗
36. 10.1021/bi00155a02010.1021/bi00155a020 ↗
37. 10.1016/S0969-2126(01)00157-510.1016/S0969-2126(01)00157-5 ↗
38. 10.1039/D3ME00100H10.1039/D3ME00100H ↗
39. 10.1246/bcsj.2019037410.1246/bcsj.20190374 ↗
40. 10.1038/s41428-023-00774-910.1038/s41428-023-00774-9 ↗
41. 10.1073/pnas.94.19.1008010.1073/pnas.94.19.10080 ↗
42. 10.1016/j.ab.2020.11390910.1016/j.ab.2020.113909 ↗
43. 10.1039/C8SC01148F10.1039/C8SC01148F ↗
44. 10.1371/journal.pone.019982910.1371/journal.pone.0199829 ↗
45. 10.1016/j.jchromb.2011.04.01810.1016/j.jchromb.2011.04.018 ↗
46. 10.1021/ma991398q10.1021/ma991398q ↗
47. 10.1021/acs.macromol.0c0002410.1021/acs.macromol.0c00024 ↗
48. 10.1016/j.jconrel.2015.11.02310.1016/j.jconrel.2015.11.023 ↗
49. 10.1016/j.jchromb.2017.05.01010.1016/j.jchromb.2017.05.010 ↗